Overview

Management of OAB in Female Patients .

Status:
Completed

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the effectiveness of mirabegron, solifenacin, tadalafil (5mg), and their combination in relieving symptoms of overactive bladder (OAB) in a double-blinded prospective randomized placebo-controlled trial.

Phase:

N/A

Details

Lead Sponsor:

Elsayed Abdelhalim Elsayed

Treatments:

Mirabegron
Tadalafil